PRISM BIOLAB
PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.
PRISM BIOLAB
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2006-11-02
Address:
Fujisawa, Kanagawa, Japan
Country:
Japan
Website Url:
http://www.prismbiolab.com
Total Employee:
11+
Status:
Active
Contact:
0466-53-8383
Total Funding:
42.13 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Font Awesome
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
VintaBio
VintaBio is a life sciences company that offers cell and gene therapy manufacturing services.
Current Employees Featured
Founder
Investors List
Eli Lilly
Eli Lilly investment in Series C - PRISM BioLab
Santec Corporation
Santec Corporation investment in Series C - PRISM BioLab
Eisai
Eisai investment in Series C - PRISM BioLab
Healthcare Innovation
Healthcare Innovation investment in Venture Round - PRISM BioLab
Ohara Pharmaceutical
Ohara Pharmaceutical investment in Venture Round - PRISM BioLab
WM Partners
WM Partners investment in Venture Round - PRISM BioLab
DBJ Capital
DBJ Capital investment in Venture Round - PRISM BioLab
CollaboSGK
CollaboSGK investment in Series C - PRISM BioLab
JAFCO
JAFCO investment in Series C - PRISM BioLab
Neostella capital
Neostella capital investment in Series C - PRISM BioLab
Official Site Inspections
http://www.prismbiolab.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.08 K
- Host name: cloudproxy10037.sucuri.net
- IP address: 192.124.249.37
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PRISM BioLab"
PRISM BioLab - PepMetics® Technology, Drug Discovery Platform
About PRISM BIOLAB. MISSION: PRISM BioLab is committed to maximizing the potential of its PepMetics ® Technology, transforming the “undruggable” to “druggable” with the aim of …See details»
About Us - PRISM BioLab
PRISM BioLab was founded in 2006 by a group of scientists dedicated to creating new drugs based on their technology of peptide mimetic small molecules. More than ten years of …See details»
Prism BioLab - Crunchbase Company Profile & Funding
PRISM BioLab may be growing as it has recently secured funding, which is a strong indicator of investor confidence and can facilitate further research, development, and expansion.See details»
PRISM BioLab - Products, Competitors, Financials, Employees ...
Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting. Sep 9, 2024. News provided by Share this article …See details»
PRISM BioLab Company Profile | Management and Employees List
[email protected]: 5: first + last: [email protected]: 6: first_last: [email protected]: Your Questions, Our Answers Get Free Access to PRISM …See details»
PRISM BIOLAB - VentureRadar
Develops proprietary small molecule drug discovery technology, focusing on undruggable targets, with two clinical-stage programs for cancer and fibrosis licensed to Japanese pharmaceutical …See details»
PRISM BioLab 2025 Company Profile: Stock …
Information on stock, financials, earnings, subsidiaries, investors, and executives for PRISM BioLab. Use the PitchBook Platform to explore the full profile.See details»
PRISM BioLab - Overview, News & Similar companies - ZoomInfo
Jan 26, 2024 PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions Eli Lilly and Company, …See details»
Ono Enters into a Collaboration Agreement with PRISM BioLab to …
Apr 25, 2024 PRISM BioLab is collaborating on new PPI targets with global and Japanese pharmaceutical companies. PepMetics® targeting CBP/beta-catenin PPIs licensed to Eisai …See details»
A Brief History of PRISM BioLab – CBM
Oct 2, 2024 Website: https://www.prismbiolab.com; Business Idea Description: PRISM BioLab develops therapeutic drugs that cure intractable diseases using their unique peptide mimic …See details»
PepMetics® Technology, Drug Discovery Platform
About PRISM BIOLAB. ミッション: PRISM BioLabはPepMetics ® 技術によって「創薬不可能」だった標的を「創薬可能」にし、治療法のなかった病気を治療することを目指しています。. PRISM BioLabは、独自の創薬プラットフォー …See details»
Life Sciences Investments - Newton Biocapital
Sep 9, 2021 Brussels, Belgium / Tokyo, Japan – 9 September 2021 – Newton Biocapital (“Newton”), a life sciences investment fund active in Europe and Japan and focused on the …See details»
PRISM BIOLAB - VentureRadar
Website: http://www.prismbiolab.com/ Develops proprietary small molecule drug discovery technology, focusing on undruggable targets, with two clinical-stage programs ...See details»
How Does PRISM BioLab Work? – CanvasBusinessModel.com - CBM
Oct 2, 2024 Website: https://www.prismbiolab.com; Mission: To develop therapeutic drugs that cure intractable diseases using unique peptide mimic technology; By harnessing the power of …See details»
PRESS RELEASE - PRISM BioLab
Sep 9, 2021 [email protected] . 26-1, Muraoka-Higashi 2-chome. Fujisawa, Kanagawa, JAPAN : www.prismbiolab.com . ADVENTURE WORKS FOURTH QUARTER EARNINGS …See details»
PRISM BioLab-PRISM BioLab Co.,Ltd-企业详情-InvestGO数据库 …
Dec 31, 2005 查看医药魔方InvestGO®数据库PRISM BioLab的公司信息。PRISM BioLab（PRISM BioLab Co.,Ltd），公司简介：PRISM BioLab was founded in 2006 by a …See details»
PRISM BioLab and… | Newton Biocapital - Life Sciences Investments
Www.prismbiolab.com. PRISM BioLab、米国製薬大手イーライリリー・アンド・カンパニーと ライセンスおよび共同研究契約を締結 株式会社 PRISM BioLab（代表取締役 竹原 大 本社：神 …See details»
PRISM BioLab, enters into a Joint Research and Licensing …
Apr 25, 2024 PRISM BioLab will utilize PepMetics ®, innovative small molecules that mimic three-dimensional structures of alpha-helix and beta-turns of peptides for drug discovery …See details»
Technology - PRISM BioLab
PepMetics TM Molecules maintain the shape and specific secondary structure of the short α-helix and β-turn peptides that are built on their proprietary technology. The stable conformation can …See details»
2024年7月2日上場予定 株式会社PRISM BioLab（206A）の分析
May 28, 2024 独自技術であるPepMetics技術は、タンパク質間相互作用（PPI：Protein-Protein Interaction）を制御するもので、低分子をターゲットにした技術とのことです。 化学合成に …See details»